Dear Colleague,

Given the large amount of data being generated from clinical studies, it’s not much of a challenge to reach your clinical goals. But we also have the ability to get key insights at lower costs and faster than ever before.

However, there are two considerations:

       a)   Can this data change a patient’s behaviours?
       b)   Even if the FDA has approved the use of non-medical devices, is there a risk that the generated data may cross regulatory boundaries?

To answer to these questions, eyeforpharma is conducting a virtual round table discussion on December 17th at 11.30 EST with three industry thought leaders:

Join us on the 17th at 11.30 am (EST) for this free webinar by registering here:

Kind regards,


Nassim Azzi
Global Project Director, eyeforpharma
t. 201-234-4804 | c. 240-406-6659 


To Unsubscribe please click here